Regulation of pathway choice in DNA repair after double-strand breaks
Current Opinion in Pharmacology · 2025-02 · 80 · 102496
DOI: 10.1016/j.coph.2024.102496 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Opinion in Pharmacology, 2025-02. Verfasst von Nitu Kumari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Indian Institute of Science, Bangalore 560012, India. Hauptthemen laut MEDLINE: DNA Breaks, Double-Stranded, DNA Repair. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 93 Literaturangaben. Gefördert von: Science and Engineering Research Board, Department of Science and Technology, Ministry of Science and Technology, India, Indo-French Centre for the Promotion of Advanced Research.
Abstract (Originalsprache)
DNA damage signaling is a highly coordinated cellular process which is required for the removal of DNA lesions. Amongst the different types of DNA damage, double-strand breaks (DSBs) are the most harmful type of lesion that attenuates cellular proliferation. DSBs are repaired by two major pathways-homologous recombination (HR), and non-homologous end-joining (NHEJ) and in some cases by microhomology-mediated end-joining (MMEJ). Preference of the pathway depends on multiple parameters including site of the DNA damage, the cell cycle phase and topology of the DNA lesion. Deregulated repair response contributes to genomic instability resulting in a plethora of diseases including cancer. This review discusses the different molecular players of HR, NHEJ, and MMEJ pathways that control the switch among the different DSB repair pathways. We also highlight the various functions of chromatin modifications in modulating repair response and how deregulated DNA damage repair response may promote oncogenic transformation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Biochemistry, Indian Institute of Science, Bangalore 560012, India.
- Biotechnology Research and Innovation Council - National Institute of Immunology (BRIC-NII), Aruna Asaf Ali Marg, New Delhi 110067, India.
- Department of Biochemistry, Indian Institute of Science, Bangalore 560012, India. Electronic address: sathees@iisc.ac.in.
- Biotechnology Research and Innovation Council - National Institute of Immunology (BRIC-NII), Aruna Asaf Ali Marg, New Delhi 110067, India; Biotechnology Research and Innovation Council - National Institute of Biomedical…
Förderung
- Science and Engineering Research Board
- Department of Science and Technology, Ministry of Science and Technology, India
- Indo-French Centre for the Promotion of Advanced Research
- Indian Institute of Science
- CSIR
- BRNS
- Department of Biotechnology, Ministry of Science and Technology, India
- Science and Technology Department of Ningxia Province
Zitieren
APA
Kumari, N., Kaur, E., Raghavan, S. C., & Sengupta, S. (2025). Regulation of pathway choice in DNA repair after double-strand breaks. Current Opinion in Pharmacology, 80, 102496. https://doi.org/10.1016/j.coph.2024.102496
Vancouver
Kumari N, Kaur E, Raghavan SC, Sengupta S. Regulation of pathway choice in DNA repair after double-strand breaks. Current Opinion in Pharmacology. 2025;80:102496. doi:10.1016/j.coph.2024.102496
BibTeX
@article{Kumari2025,
author = {Kumari, Nitu and Kaur, Ekjot and Raghavan, Sathees C and Sengupta, Sagar},
title = {Regulation of pathway choice in DNA repair after double-strand breaks},
journal = {Current Opinion in Pharmacology},
year = {2025},
volume = {80},
pages = {102496},
doi = {10.1016/j.coph.2024.102496}
}
EUVIMED